Angela Orcurto
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 10
- CAR-T cell therapy research 7
- Colorectal Cancer Treatments and Studies 2
-
- Immunotherapy and Immune Responses 7
-
- SARS-CoV-2 and COVID-19 Research 1
-
- Influenza Virus Research Studies 1
-
- Diabetes and associated disorders 1
-
- Myasthenia Gravis and Thymoma 1
Angela Orcurto
15 papers receiving 397 citations
Peers
Comparison fields: 5 of 75
- Oncology 267
- Immunology 165
- Complementary and alternative medicine 52
- Drug Discovery 1
- Pharmacology 17
Countries citing papers authored by Angela Orcurto
This map shows the geographic impact of Angela Orcurto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Orcurto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Orcurto more than expected).
Fields of papers citing papers by Angela Orcurto
This network shows the impact of papers produced by Angela Orcurto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Orcurto. The network helps show where Angela Orcurto may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Angela Orcurto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 48 | |
| 2 | 2022 | 0 | |
| 3 | 2021 | 6 | |
| 4 | 2021 | 20 | |
| 5 | [Immunotherapy for bladder cancer in 2021]. | 2021 | 1 |
| 6 | 2021 | 0 | |
| 7 | 2020 | 12 | |
| 8 | 2020 | 6 | |
| 9 | 2020 | 4 | |
| 10 | 2019 | 84 | |
| 11 | 2019 | 174 | |
| 12 | 2019 | 1 | |
| 13 | [Side effects of immune checkpoint inhibitors: diagnosis and management]. | 2019 | 2 |
| 14 | 2018 | 3 | |
| 15 | [Endocrine therapy resistance in metastatic breast cancer: mechanisms and clinical implications]. | 2014 | 4 |
| 16 | 2014 | 23 | |
| 17 | 2012 | 17 |
About Angela Orcurto
Angela Orcurto is a scholar working on Oncology, Immunology and Complementary and alternative medicine, having authored 17 papers that have together received 405 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), CAR-T cell therapy research (7 papers), Immunotherapy and Immune Responses (7 papers), Colorectal Cancer Treatments and Studies (2 papers), SARS-CoV-2 and COVID-19 Research (1 paper), Influenza Virus Research Studies (1 paper), Diabetes and associated disorders (1 paper) and Myasthenia Gravis and Thymoma (1 paper). The work is most often cited by research in Oncology (267 citations), Immunology (165 citations) and Complementary and alternative medicine (52 citations). Angela Orcurto has collaborated with scholars based in Switzerland, United States and Greece. Frequent co-authors include Pierre‐Yves Rodondi, Lana E. Kandalaft, Julie Dubois, Thierry Buclin, Laura E. Rothuizen, Chantal Csajka, George Coukos, Khalil Zaman, Michal J. Besser and Christopher A. Klebanoff. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.